The methylation status of the ADAM17 promoter was markedly higher in BRCA, KIRC, KIRP, LUSC, PAAD, PRAD, SARC, and SKCM tumor tissues than in paired normal tissues (Figure 1F–M). The gene discussed is ADAM17; the disease is pancreatic adenocarcinoma.